Yahoo Web Search

Search results

1. • Reviva Pharmaceuticals (NASDAQ:RVPH) vs. Bristol-Myers Squibb (NYSE:BMY) Head to Head Survey

     ETF DAILY NEWS· 2 days ago

     Bristol-Myers Squibb (NYSE:BMY – Get Free Report) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) are both medical companies, but which is the better investment? We will compare the ...

2. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 7 days ago

     Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Ventyx Biosciences, Inc ...

3. • SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...

     WFRV 5 Green Bay· 6 days ago

     Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...

4. • VENTYX BIOSCIENCES, INC. (NASDAQ: VTYX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Ventyx...

     Morningstar· 5 days ago

     Do you, or did you, own shares of Ventyx Biosciences, Inc. (NASDAQ: VTYX)? Did you purchase your shares pursuant and/or traceable to the Company’s October 21, 2021 IPO, or between October 21 ...

5. • Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit...

     Morningstar· 2 days ago

     LOS ANGELES, April 24, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 30, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of Ventyx Biosciences, Inc. (“Ventyx” or

6. • UBS Group Trims Amgen (NASDAQ:AMGN) Target Price to $284.00

     ETF DAILY NEWS· 7 days ago

     Amgen (NASDAQ:AMGN – Free Report) had its price objective trimmed by UBS Group from $314.00 to $284.00 in a research note released on Wednesday morning, Benzinga reports. The brokerage currently ...

7. • Amgen Inc. (NASDAQ:AMGN) Stock Position Decreased by PSI Advisors LLC

     ETF DAILY NEWS· 5 days ago

     PSI Advisors LLC lessened its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 31.8% in the fourth quarter, according to the company in its most recent filing with the Securities ...

8. • 

     5 Crash-Proof Stocks to Buy Immediately

     InvestorPlace· 5 days ago

     In February, I recommended five one-month momentum plays to buy as Bitcoin (BTC-USD) prices surged. The world’s largest cryptocurrency is a surprisingly...

9. • Hussman Strategic Advisors Inc. Reduces Stock Holdings in Amgen Inc. (NASDAQ:AMGN)

     ETF DAILY NEWS· 5 days ago

     Hussman Strategic Advisors Inc. lessened its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 60.0% in the 4th quarter, Holdings Channel reports. The institutional investor owned ...

10. • UCB SA (OTCMKTS:UCBJY) Declares Dividend of $0.46

      ETF DAILY NEWS· 6 days ago

      UCB SA (OTCMKTS:UCBJY – Get Free Report) declared a dividend on Friday, April 19th, investing.com reports. Stockholders of record on Monday, April 29th will be given a dividend of 0.4574 per ...